5060 Comparable efficacy of low-dose (1,000 mg/m2 b.i.d.) capecitabine and standard-dose (1,250 mg/m2 b.i.d.) capecitabine administered for ≥6 weeks in older women with advanced breast cancer

✍ Scribed by E. Bajetta; G. Procopio; L. Celio

• Book ID: 119600710
• Publisher: Elsevier Science
• Year: 2009
• Tongue: English
• Weight: 66 KB
• Volume: 7
• Category: Article
• ISSN: 1359-6349
• DOI: 10.1016/s1359-6349(09)70952-8